AMALFI Trial: How Patch-Based ECG Monitoring Co...

By Rene Pretorius

August 29, 2025

Imagine detecting a silent heart condition before it triggers a devastating stroke. The AMALFI ran...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
FDA Guidance on Overall Survival Assessment in Oncology Trials
Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditiona...
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Rare Medications Coverage in the Netherlands: Price Reductions Required
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...